company background image
CVS logo

CVS Health NYSE:CVS Lagerbericht

Letzter Preis

US$57.85

Marktkapitalisierung

US$71.0b

7D

-3.6%

1Y

-21.8%

Aktualisiert

08 Aug, 2024

Daten

Finanzdaten des Unternehmens +

Community Narratives

Narratives bring a range of perspectives from our community.

US$69.1

FV  

16.3% undervalued intrinsic discount

4.99%

Revenue growth p.a.

0users have liked this narrative

0users have commented on this narrative

0users have followed this narrative

16 days agoauthor updated this narrative

JU
julio
Community Contributor

CVS VALUATION

US$63.3

FV  

8.7% undervalued intrinsic discount

9.19%

Revenue growth p.a.

0users have liked this narrative

0users have commented on this narrative

0users have followed this narrative

about 1 month agoauthor updated this narrative

CVS Health Corporation Wettbewerber

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für CVS Health
Historische Aktienkurse
Aktueller AktienkursUS$57.85
52-Wochen-HochUS$83.25
52-Wochen-TiefUS$52.77
Beta0
11 Monat Veränderung0.40%
3 Monate Veränderung3.64%
1 Jahr Veränderung-21.78%
33 Jahre Veränderung-32.05%
5 Jahre Veränderung-1.68%
Veränderung seit IPO8,711.59%

Aktuelle Nachrichten und Updates

A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

Aug 08
A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run

Aug 07

Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

Jul 21
Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

Recent updates

A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

Aug 08
A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run

Aug 07

Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

Jul 21
Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

CVS Health: A Better Investment Than Walgreens Boots Alliance

Jul 09

Vltava Fund - CVS Health Corp.: Why We Sold CVS

Jul 03

CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell

Jun 21

The Correct Play On CVS Health

Jun 06

CVS Health: Downside Movement Is Overdramatic

May 26

CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity

May 15

We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

CVS Health: A Terrible Earnings Report, But An Undervalued Stock

May 04

CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 03
CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot

Apr 22

Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

Apr 14
Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date

Apr 10

Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

Mar 27
Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

CVS Health: Better Times Likely Ahead

Mar 12

CVS Health: Lower Guidance But Risk/Reward Remains Attractive

Feb 15

CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance

Feb 07

CVS Health: Back In The Buy Column

Jan 21

CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

Jan 17
CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength

Jan 08

CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

Jan 03
CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

CVS Health: Risk/Reward Highly Skewed To The Upside

Dec 15

CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

Dec 13
CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

Dec 08
We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

CVS Health: A Good Fit To Buffett's 10x Pretax Rule

Dec 07

Aktionärsrenditen

CVSUS HealthcareUS Markt
7D-3.6%-3.0%-5.7%
1Y-21.8%5.6%14.1%

Rendite im Vergleich zur Industrie: CVS unter dem Niveau der Branche US Healthcare , die im vergangenen Jahr eine Rendite von 3.5% erzielte.

Rendite vs. Markt: CVS hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 22.3 erzielte.

Preisvolatilität

Is CVS's price volatile compared to industry and market?
CVS volatility
CVS Average Weekly Movement4.3%
Healthcare Industry Average Movement7.4%
Market Average Movement6.2%
10% most volatile stocks in US Market14.6%
10% least volatile stocks in US Market3.2%

Stabiler Aktienkurs: CVS hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: CVSDie wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
1996259,500Karen Lynchwww.cvshealth.com

Die CVS Health Corporation bietet in den Vereinigten Staaten Gesundheitslösungen an. Das Unternehmen ist in den Segmenten Health Care Benefits, Health Services und Pharmacy & Consumer Wellness tätig. Das Segment Health Care Benefits bietet traditionelle, freiwillige und verbraucherorientierte Krankenversicherungsprodukte und damit verbundene Dienstleistungen an.

CVS Health Corporation's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von CVS Health im Vergleich zum Marktanteil des Unternehmens?
CVS grundlegende Statistiken
MarktanteilUS$71.04b
Gewinn(TTM)US$7.19b
Umsatz(TTM)US$362.70b

10.1x

Kurs-Gewinn-Verhältnis

0.2x

Kurs-Umsatz-Verhältnis

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
CVS Gewinn- und Verlustrechnung (TTM)
EinnahmenUS$362.70b
Kosten der EinnahmenUS$309.85b
BruttogewinnUS$52.85b
Sonstige AusgabenUS$45.66b
UmsatzUS$7.19b

Zuletzt gemeldete Gewinne

Jun 30, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)5.72
Bruttomarge14.57%
Nettogewinnspanne1.98%
Schulden/Eigenkapital-Verhältnis88.4%

Wie hat sich CVS auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

4.6%

Aktuelle Dividendenrendite

45%

Ausschüttungsquote